- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab ; volume:12 ; number:2 ; year:2019 ; pages:621-624
Case reports in oncology ; 12, Heft 2 (2019), 621-624
- Creator
-
Tonk, Erwin H.J.
van Lindert, Anne S.R.
Verhoeff, Joost J.C.
Suijkerbuijk, Karijn P.M.
- DOI
-
10.1159/000502202
- URN
-
urn:nbn:de:101:1-2019091200470320912636
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tonk, Erwin H.J.
- van Lindert, Anne S.R.
- Verhoeff, Joost J.C.
- Suijkerbuijk, Karijn P.M.
Other Objects (12)
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
Early onset recall pneumonitis during targeted therapy with sunitinib
Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
Arzneimittel Profil Durvalumab
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis
Retinal Vasculitis Secondary to Durvalumab
Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide
High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
Early onset recall pneumonitis during targeted therapy with sunitinib
Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
Arzneimittel Profil Durvalumab
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis
Retinal Vasculitis Secondary to Durvalumab
Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide
High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
Early onset recall pneumonitis during targeted therapy with sunitinib
Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
Arzneimittel Profil Durvalumab
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis
Retinal Vasculitis Secondary to Durvalumab
Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide